Translational reprogramming drives chromosomal instability during tumorigenesis

Cancer is often described as a disease of the genome, a state where the instructions inside a cell become scrambled. A central feature of this chaos is chromosomal instability, a condition where cells fail to divide correctly, losing or gaining entire chromosomes in the process. This instability fuels the evolution of tumors, allowing them to grow, spread, and resist treatment. For decades, scientists have known that errors in the machinery of cell division are a primary cause of this instability. However, the precise moment when a healthy cell tips over the edge into this chaotic state has remained a mystery. Specifically, researchers have struggled to understand what triggers these division errors in the very early stages of cancer, before a tumor has fully formed. While it is known that certain genes, such as those involved in cell signaling, are frequently lost in cancer, the chain of events connecting that loss to the physical breaking of chromosomes has been unclear.

A new study from researchers at the Peter MacCallum Cancer Centre and their collaborators has uncovered a surprising link in this chain. They found that the loss of a specific gene, known as SMAD4, which is common in cancers of the digestive system, does not just stop a cell from receiving growth signals. Instead, it fundamentally rewires how the cell reads its own genetic instructions. This rewiring causes the cell to stop producing a specific protein essential for keeping chromosomes aligned during division. Without this protein, the cell begins to make mistakes every time it splits, leading to the genomic chaos that drives tumor growth. The researchers demonstrated that by restoring just this single missing protein, they could stop the division errors and prevent the cells from becoming cancerous in animal models.

The investigation began with a focus on esophageal adenocarcinoma, a type of cancer that develops in the lower part of the food pipe. This disease often arises from a precancerous condition called Barrett's esophagus, where the lining of the esophagus changes due to chronic acid reflux. In these early stages, cells often lose the function of a gene called TP53, a well-known guardian of the genome. Yet, losing TP53 alone does not always lead to the massive chromosomal instability seen in advanced tumors. The researchers noticed that when cells also lost the SMAD4 gene, the level of genomic chaos increased dramatically. To test if this was a general rule, they analyzed data from thousands of patients with various gastrointestinal cancers, including those of the stomach, pancreas, and colon. The data confirmed a consistent pattern: tumors with lost SMAD4 function showed significantly higher rates of chromosomal errors, but only when the TP53 gene was also compromised. This suggested that SMAD4 acts as a critical gatekeeper, preventing instability even when other safeguards have failed.

To understand how SMAD4 performs this protective role, the team turned to laboratory models using human cells that mimic the early stages of Barrett's esophagus. They used a precise gene-editing tool to remove the SMAD4 gene from these cells, creating a model of the disease in a dish. They then watched these cells divide under a microscope over many hours. The cells without SMAD4 did not divide faster or slower than normal cells, but they made far more mistakes. Chromosomes that should have lined up perfectly in the center of the cell drifted apart, and some failed to separate cleanly, leaving behind tiny, extra nuclei in the daughter cells. These errors are the physical signature of chromosomal instability. The researchers also observed that the nuclei of these defective cells became larger and more variable in size, a hallmark of cells that have accumulated genetic damage over time.

The next step was to find out why the cells were making these mistakes. The team suspected that the problem might not be in the genes themselves, but in how the cell used them. They compared the total amount of genetic instructions (RNA) in normal cells versus SMAD4-deficient cells and found that the levels were largely the same. However, when they looked at which instructions were actually being read and turned into proteins, a different picture emerged. The SMAD4-deficient cells had reprogrammed their internal factory. They were prioritizing the production of short, simple proteins while largely ignoring longer, more complex ones. This shift was driven by an overactive signaling pathway known as mTOR, which acts as a master regulator of protein production. In the absence of SMAD4, this pathway became hyperactive, forcing the cell to focus its energy on a specific set of messages while neglecting others.

Among the messages that were neglected was one for a protein called CDK11B. This protein exists in different versions, but one specific version, known as the p58 isoform, is produced only during cell division and is essential for ensuring chromosomes separate correctly. The researchers found that while the cell still contained the instructions to make CDK11B, the machinery that builds proteins was failing to translate those instructions into the p58 version. The cell was effectively ignoring the manual for the most critical part of its division process. This was not a random failure; the CDK11B instructions are unusually long and complex, fitting the profile of the messages that the reprogrammed cell was systematically skipping.

To prove that this missing protein was the direct cause of the division errors, the researchers performed a rescue experiment. They took the SMAD4-deficient cells, which were prone to making mistakes, and artificially added back the instructions to make the p58 version of CDK11B. The result was immediate and striking. The cells suddenly stopped making the chromosome errors they had been prone to. The lagging chromosomes disappeared, and the cells divided cleanly. Furthermore, when these corrected cells were injected into mice, they failed to form tumors. In contrast, the cells without the added protein grew into large, aggressive tumors. This confirmed that the loss of CDK11B-p58 was the specific mechanism by which the loss of SMAD4 led to cancer.

The study also explored how this process accelerates tumor growth. The researchers found that the combination of losing SMAD4 and disabling other genes that normally keep the protein-making machinery in check, such as PTEN or TSC2, caused tumors to form four times faster in mice. This suggests that the initial loss of SMAD4 creates a fragile state where cells are desperate for any additional change that helps them survive. The overactive protein production pathway provides a temporary boost, but it comes at the cost of genomic stability. Over time, the accumulation of division errors allows the cells to acquire the mutations they need to become fully malignant.

This work changes the understanding of how cancer begins. It shows that the transition from a healthy cell to a cancerous one is not just a matter of turning growth switches on or off. It is also a failure of the cell's ability to read its own complex instructions correctly. The loss of SMAD4 triggers a chain reaction that alters the cell's focus, causing it to drop the very tools it needs to divide safely. By identifying this specific failure in protein production, the researchers have highlighted a new vulnerability in cancer cells. If scientists can find ways to restore the production of these critical proteins, or to target the overactive pathways that suppress them, they may be able to stop tumors before they ever take hold. The findings suggest that the key to preventing some of the most aggressive cancers may lie not in stopping growth, but in ensuring the cell's internal factory continues to build the right parts at the right time.